Skip to main content
. 2021 Mar 14;27(10):959–975. doi: 10.3748/wjg.v27.i10.959

Table 4.

Comparison of the parameter decrease degree in subgroups with weight loss of more and less than 5% from baseline to the end of treatment

Parameter
Weight loss > 5% (n = 54)
Weight loss ≤ 5% (n = 120)
P value
∆ALT, U/L -21.1 (-45.0; -6.0) -25.0 (-42.5; -6.0) 0.683
∆ALT, % -46 (-63; -18) -43 (-54; -23) 0.281
∆AST, U/L -6.0 (-15.0; 1.6) -5.0 (-18.0; 1.0) 0.673
∆AST, % 22 (-41; 0) -17 (-42; 0) 0.446
∆GGT, U/L -5.0 (-17.0; 0) -8.0 (-22.5; 0) 0.492
∆GGT, % -19 (-41; 0) -32 (-50; 0) 0.354
∆TC, mmol/L -0.10 (-0.66; 0.30) -0.10 (-0.57; 0.2) 0.666
∆TG, mmol/L -1.04 (-1.80; -0.23) -0.70 (-1.33; -0.11) 0.079
∆LDL, mmol/L -0.20 (-0.7; 0.2) -0.14 (-0.58; 0.3) 0.401
FLI
Initially 88.3 ± 10.2 83.5 ± 10.3 0.002
After 6 mo 71.4 ± 19.6c 72.8 ± 16.7c 0.916
∆FLI -14.6 (-21.8; -6.3) -8.45 (-17.9; -2) 0.003
c

P < 0.001. ∆ is the difference in indicators after 6 mo and at baseline. The minus sign indicates a decrease in the parameter by the end of the study.